Recognition

Applying decades of collective experience, we serve as advisors and advocates, using our legal, business, media, and political acumen to advance the interests of our clients and the public.

We enjoy a national reputation as a go-to firm for our legal, legislative, and regulatory work surrounding health care access, opioids and other controlled medications, drug diversion and abuse prevention, addiction treatment, pain management, and drug testing.

Our legal and policy professionals provide education, analysis, and commentary on issues of importance to our clients and the public through scholarly publications, national conferences, and the news media.

DCBA’s attorneys, advisors, and law clerks have published the following peer-reviewed, scholarly articles:

Michael C. Barnes, A More Sensible Surge: Ending DOJ’s Indiscriminate Raids of Healthcare Providers, 8.1 Legis. & Pol’y Brief 7 (2019).

Michael C. Barnes & Daniel C. McClughen, Warm Handoffs: The Duty of and Legal Issues Surrounding Emergency Departments in Reducing the Risk of Subsequent Drug Overdoses, 48 U. Mem. L. Rev. 1100 (2019).

Michael C. Barnes, et al., Potential Impact of Texas et al v United States on Persons with Substance Use Disorder, ABA Health eSource (Oct. 2018).

Michael C. Barnes, Diligence and Documentation: Managing the Risks of Prescribing Controlled Substances, 5 PainWeek J. 52 (2017).

Stacey L. Worthy, et al., The Compounding Conundrum: How Insufficient Delineation of Regulatory Responsibility Has Created a Need for State and Federal Compounding Drug Law Reform, 72(3) Food & Drug L.J. (2017).

Stacey L. Worthy, et al., Now or Never: The Urgent Need for Action Against Unfair Coverage Denials for Quality Health Care, 48 Loy. U. Chi. L.J. 1041 (2017).

Gary Branning & Stacey L. Worthy, Emphasize Shared Decision-Making Between Physicians & Patients to Improve Diabetes Outcomes, 10 Am. Health & Drug Benefit J. 242 (2017).

Daniel C. McClughen & Marsha Stanton, The CDC Guideline and its Impact on Delivering Patient-Centered Care, 18 Pain Mgmt. Nursing 5 (2017).

Shruti R. Kulkarni, et al., What’s in a number? Recommending practicality in the DATA 2000 patient limits, 12(4) J. Opioid Mgmt. 243 (2016).

Stacey L. Worthy, Don’t Sell Out Safety: A Call to Preserve Risk Evaluation and Mitigation Strategies to Reduce Harm to Patients and the Public in the U.S., 9:2 J. Pharmaceutical Pol’y & Practice 1 (2016).

Michael C. Barnes, et al., A Call for Differential Diagnosis of Non-Specific Low Back Pain to Reduce Opioid Abuse, 101 J. Med. Reg. 39 (2015).

Michael C. Barnes & Stacey L. Worthy, Evaluating Motives: Two Simple Tests to Identify and Avoid Entanglement in Legally Dubious Urine Drug Testing Schemes, 11 J. Opioid Mgmt. 89 (2015).

Michael C. Barnes, et al.,  Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, 6 Therapeutic Advances in Drug Safety 1 (2015).

Michael C. Barnes & Stacey L. Worthy, Achieving Real Parity: Increasing Access to Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act and the Mental Health and Addiction Equity Act, 36 U Ark Little Rock L. Rev. 555 (2015).

Michael C. Barnes & Stacey L. Sklaver, Applying Lessons from the Opioid Abuse Epidemic to Protect Consumers from Gray Market Biologics, 29 Notre Dame J.L. Ethics & Pub. Pol’y 375 (2015).

Stacey L. Worthy & Jason F. Kozak, Follow-on Biologics: Protecting Consumers through State Pharmacy Law in Light of FDA Actions, 17 Quinnipiac Health L.J. 207 (2014).

Michael C. Barnes & Stacey L. Sklaver, Active Verification and Vigilance: A Method To Avoid Civil and Criminal Liability When Prescribing Controlled Substances, 15 DePaul J. Health Care L. 93 (2013).

Michael C. Barnes & Gretchen Arndt, The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse, 16 J. Health Care L. & Pol’y 271 (2013).

Michael C. Barnes, et al., A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1 & Part 2, 3(4) J. Global Drug Pol’y & Prac. (2009).

Our attorneys have presented at the following conferences, among many others:

American Academy of Pain Medicine
Addiction Executives Industry Summit
American Society of Addiction Medicine
American Society of Plastic Surgeons
The Economist: War on Cancer
FDA/CMS Summit
International Conference on Opioids
National Association of Attorneys General
National Association of State Controlled Substances Authorities
National Conference of State Legislatures
National Rx Drug Abuse and Heroin Summit
National Sheriffs’ Association

For a full listing of our attorneys’ speaking engagements, view our bios.

Our attorneys and advisors have provided thought leadership and analysis to news organizations including:

Alcohol & Drug Abuse Weekly
Associated Press
Behavioral Healthcare Executive
Bloomberg
Bustle
BuzzFeed
CBS News
CNBC
CNN
FDA Week
FierceHealthcare
FOX Business
FOX News
Inc. Magazine

InsideHealthPolicy
HLN
Morning Consult
MSNBC
Newsweek
The Hill
The New Yorker
The New York Times
RealClearHealth
Reuters
Time Magazine
Tonic
Vox
The Wall Street Journal
WebMD

Recognition

Publications

Speaking Engagements

News Media